Pharma Mar (OTCMKTS:PHMMF) Reaches New 12-Month High – Should You Buy?

Pharma Mar, S.A. (OTCMKTS:PHMMF)’s stock price reached a new 52-week high during trading on Wednesday . The stock traded as high as $75.00 and last traded at $75.00, with a volume of 0 shares trading hands. The stock had previously closed at $75.00.

Analysts Set New Price Targets

Separately, Chardan Capital raised Pharma Mar to a “strong-buy” rating in a research note on Thursday, August 1st.

Pharma Mar Stock Performance

The company has a debt-to-equity ratio of 0.14, a current ratio of 2.55 and a quick ratio of 2.01. The company’s 50-day simple moving average is $57.03 and its 200-day simple moving average is $40.93.

Pharma Mar Company Profile

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.